More than ever before, the past 18 months has outlined the need for rapid, scalable and cost-effective vaccine, diagnostic, and therapeutic development. It also showcased the importance of flexibility and the need for the biopharmaceutical manufacturing industry to adapt to changing market demands. KENX is excited to announce the Biopharmaceutical Manufacturing University event taking place November 9 – 11 in San Diego. This hybrid-format program will provide you with real world case studies and industry insights as to how the biopharma manufacturing industry can transform for a better future.
Topics Being Covered at the Biopharmaceutical Manufacturing University Hybrid Event Include:
Understanding Process Validation in Biotechnology Manufacturing
Smart Collaboration – R&D and Manufacturing Breaking Down Barriers for Better Efficiencies
Examining How New Technologies are Affecting Biopharmaceutical Manufacturing
Reflecting on the Growing Momentum for Biosimilars in the US
Creating an Agile Culture to Be Ready to Adapt to New Innovative Ways of Working
Discovering how Covid-19 has Changed Biopharmaceutical Manufacturing Forever Delivery
Removing Bottlenecks: Improving the Supply Chain for the Biopharma Industry
Data Integrity and Biopharmaceutical Manufacturing
Remote Observation Technologies – Revolutionizing the Pharma Manufacturing Space
Technology Advancements for Drug Product Manufacturing
Challenges to Designing and Constructing Optimal Facilities for the Production of Cell & Gene Therapies
The Changing Regulatory Processes after The Global Pandemic
Cautionary Tales of Centralized Pharmaceutical Manufacturing
Advances in Next-Generation Drug Substance Manufacturing of Biologics
The Digitization of CMC – The Future for Regulatory Submissions
Moving from Change Management to Enterprise Transformation
What is the Vision for AI in Biopharma Manufacturing?
Data Analytics in Biopharma Manufacturing
Barriers to User-Adoption of Innovative Technology in Biopharmaceutical Manufacturing
The Potential of Hybrid Process Modeling and Digital Twins to Master the Goals of Bioprocessing 4.0
What Does a Modern BioPharmaceutical Manufacturing Facility Look Like?
The Rapid Adoption of Intelligent Manufacturing and Pharma 4.0 During Covid
Rapid and Cost-Effective Deployment of Modular Biopharma Manufacturing Facilities
Who Should Attend:
Attendees will come from biopharmaceutical companies, pharma, biotech companies, medtech companies and their peripherals across the globe and will bring together all those individuals involved with the manufacturing process.
Titles will include:
Chief Engineering Officer
Chief Manufacturing Officer
Chief Scientific Officer
Chief Innovation Officer
Chief Technology Officer
Chief Operations Officer
Chief Quality Officer
Chief Data Analytics Officer
VPs/Directors/Managers & Heads of:
R&D / Research & Development
Data & Analytics
SPECIAL PRICING (1)
Simply fill out this form below to register for the conference. KENX will arrange invoicing and will provide you with a log-in to the virtual platform and in-person details.